Αποτελέσματα Αναζήτησης
15 Νοε 2023 · This version of the Guidelines gives recommendations on CV risk stratification as well as on screening, diagnosis, and treatment of CVD in patients with diabetes. Based on evidence from large CVOTs, the current Guidelines provide clear recommendations on how to reduce cardiovascular risk in patients with diabetes and how to treat patients with ...
25 Αυγ 2023 · Randomized controlled trials have shown the benefit (reduction of stroke, coronary events, and kidney disease) of lowering SBP to <140 mmHg and diastolic blood pressure (DBP) to <90 mmHg in patients with diabetes. However, the optimal BP target in patients with diabetes is still a matter of debate.
21 Φεβ 2019 · Novel and emerging targets for therapeutic intervention in diabetic cardiovascular disease, such as RNA therapeutics and targeting the RAGE (receptor for advanced glycation endproducts) axis, also hold promise to reduce the burden that diabetes mellitus poses to the cardiovascular system.
Peripheral arterial disease (PAD) refers to partial or complete occlusion of the peripheral vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in the coronary and cerebral arteries. The prevalence of PAD is ...
14 Ιουν 2016 · Understanding the mechanisms, strategies for and challenges with managing ASCVD and heart failure risk in diabetes mellitus, as well as the potential cardiovascular risks and benefits of glucose-lowering drugs, is important for managing cardiovascular disease in diabetes mellitus.
2 Μαΐ 2013 · This review will focus on the most current advances in the pathophysiology of vascular disease (Part I) and will address clinical manifestations and management strategies of patients with diabetes (Part II).
10 Απρ 2023 · Diabetic panvascular disease (DPD) is a clinical syndrome in which vessels of various sizes, including macrovessels and microvessels in the cardiac, cerebral, renal, ophthalmic, and...
